Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
Kidney International Reports
|
November 29, 2023
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases
Daniel Leung, Eugene Yu-Hin Chan, Xiaofeng Mu, et al.
Kidney International Reports
|
October 18, 2023
Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney Diseases
Eugene Yu-Hin Chan, Daniel Leung, Samuel M S Cheng, et al.
Nature Communications
|
June 28, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Signal Transduction and Targeted Therapy
|
December 14, 2022
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
Xiaofeng Mu, Carolyn A Cohen, Daniel Leung, et al.
Nature Communications
|
August 26, 2024
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants
Xiang Liu, Wern Hann Ng, Eva Zusinaite, et al.
Nature Communications
|
August 15, 2022
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Frontiers in Immunology
|
October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
Daniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
World Journal of Pediatrics : WJP
|
December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents
Jaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 16, 2024
SARS-CoV-2-specific CD8<sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years
Louise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
Viruses
|
January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
Polina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
Kidney International Reports
|
November 29, 2023
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases
Daniel Leung, Eugene Yu-Hin Chan, Xiaofeng Mu, et al.
Kidney International Reports
|
October 18, 2023
Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney Diseases
Eugene Yu-Hin Chan, Daniel Leung, Samuel M S Cheng, et al.
Nature Communications
|
June 28, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Signal Transduction and Targeted Therapy
|
December 14, 2022
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
Xiaofeng Mu, Carolyn A Cohen, Daniel Leung, et al.
Nature Communications
|
August 26, 2024
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants
Xiang Liu, Wern Hann Ng, Eva Zusinaite, et al.
Nature Communications
|
August 15, 2022
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Frontiers in Immunology
|
October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
Daniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
World Journal of Pediatrics : WJP
|
December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents
Jaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 16, 2024
SARS-CoV-2-specific CD8<sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years
Louise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
Viruses
|
January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
Polina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Page
of 14